Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Fusion Pharmaceuticals Inc. FUSN

Full chart Compare
Set alert

Price alert · FUSN

All alert types
21.55 +21.55

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

11.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.6×
FY 2017: -50.0×FY 2018: -27.4×FY 2019: -170×FY 2020: -3.3×FY 2021: -2.2×FY 2022: -1.6×FY 2023: -6.6×
FY 2017 5y median -3.3× FY 2023
P/S 305×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 123×FY 2022: 94.3×FY 2023: 305×
FY 2017 5y median 94.3× FY 2023
P/B 2.8×
FY 2017: 0.0×FY 2018: -17.7×FY 2019: -79.0×FY 2020: 0.9×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 2.8×
FY 2017 5y median 0.8× FY 2023
P/FCF -7.4×
FY 2017: -51.1×FY 2018: -28.9×FY 2019: -187×FY 2020: -8.4×FY 2021: -2.3×FY 2022: -1.8×FY 2023: -7.4×
FY 2017 5y median -7.4× FY 2023
EV/EBITDA -7.1×
FY 2017: 0.0×FY 2018: -30.0×FY 2019: -144×FY 2020: -2.2×FY 2021: -1.6×FY 2022: -1.5×FY 2023: -7.1×
FY 2017 5y median -2.2× FY 2023
EV/Sales 299×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 91.3×FY 2022: 91.9×FY 2023: 299×
FY 2017 5y median 91.3× FY 2023
FCF Yield -13.6%
FY 2017: -2.0%FY 2018: -3.5%FY 2019: -0.5%FY 2020: -11.9%FY 2021: -43.5%FY 2022: -54.7%FY 2023: -13.6%
FY 2017 5y median -13.6% FY 2023

Profitability

Gross Margin 35.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -3813.7%FY 2022: -3931.1%FY 2023: 35.0%
FY 2017 5y median 0.0% FY 2023
Operating Margin -4798.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -5695.5%FY 2022: -6025.6%FY 2023: -4798.5%
FY 2017 5y median -4798.5% FY 2023
Net Margin -4588.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -5628.3%FY 2022: -5996.7%FY 2023: -4588.8%
FY 2017 5y median -4588.8% FY 2023
ROE -42.7%
FY 2017: 0.0%FY 2018: 65.0%FY 2019: 48.3%FY 2020: -26.6%FY 2021: -35.0%FY 2022: -54.0%FY 2023: -42.7%
FY 2017 5y median -35.0% FY 2023
ROIC -36.2%
FY 2017: 0.0%FY 2018: -33.9%FY 2019: -28.0%FY 2020: -12.7%FY 2021: -34.0%FY 2022: -42.0%FY 2023: -36.2%
FY 2017 5y median -34.0% FY 2023
ROA -33.2%
FY 2017: 0.0%FY 2018: -37.1%FY 2019: -23.3%FY 2020: -25.2%FY 2021: -32.1%FY 2022: -40.0%FY 2023: -33.2%
FY 2017 5y median -32.1% FY 2023

Growth (YoY)

Revenue 41.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 1.5%FY 2023: 41.5%
FY 2017 FY 2023
Operating Income -12.7%
FY 2017: 0.0%FY 2018: -44.6%FY 2019: -80.4%FY 2020: -108.2%FY 2021: -116.2%FY 2022: -7.3%FY 2023: -12.7%
FY 2017 FY 2023
EPS (diluted) 27.5%
FY 2017: 0.0%FY 2018: -82.4%FY 2019: 83.9%FY 2020: -3460.0%FY 2021: 46.6%FY 2022: -5.3%FY 2023: 27.5%
FY 2017 FY 2023
Free Cash Flow -13.6%
FY 2017: 0.0%FY 2018: -76.6%FY 2019: -28.7%FY 2020: -118.4%FY 2021: -150.0%FY 2022: 2.3%FY 2023: -13.6%
FY 2017 FY 2023

Financial Health

Current Ratio 15.0×
FY 2017: 0.0×FY 2018: 18.9×FY 2019: 15.6×FY 2020: 19.2×FY 2021: 16.9×FY 2022: 11.9×FY 2023: 15.0×
FY 2017 5y median 15.6× FY 2023
Quick Ratio 15.0×
FY 2017: 0.0×FY 2018: 18.4×FY 2019: 15.5×FY 2020: 18.9×FY 2021: 16.9×FY 2022: 12.5×FY 2023: 15.0×
FY 2017 5y median 15.5× FY 2023
Debt / Equity 0.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -0.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.2×FY 2023: 0.2×
FY 2017 5y median 0.0× FY 2023
Net Debt / EBITDA 0.1×
FY 2017: 0.0×FY 2018: 3.0×FY 2019: 3.3×FY 2020: 1.2×FY 2021: 0.6×FY 2022: 0.0×FY 2023: 0.1×
FY 2017 5y median 0.6× FY 2023
Interest Coverage -19.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -116×FY 2021: 0.0×FY 2022: -48.9×FY 2023: -19.2×
FY 2017 5y median -19.2× FY 2023

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2017 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2017 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31